Close

Posaconazole

Interaction with Ondansetron

Not Applicable (no data on interaction)
QT risk: Posaconazole Ondansetron

QT effect

Posaconazole: Conditional QT risk

Substantial evidence reports that this drug causes QT prolongation and has a risk of TdP, but only under certain known conditions (e.g. excessive dose, drug interaction, etc.).

References

Ondansetron: QT risk

Substantial evidence reports that this drug prolongs the QT interval and has a risk of causing TdP (when used as directed in labeling).

References

  • SPC Ondansetron